In this episode, we welcome Dr. Jason Hurt, a clinician-scientist and entrepreneur with deep expertise in radiopharmaceutical development, clinical trial strategy, and oncology drug development.
Dr. Hurt is the founder of Theragnostic Insights, a consulting and strategic advisory firm launched in March 2025 that is dedicated to advancing theranostic solutions and radioligand therapies.
